Documentation Insurance Specialty Pharmacies 
STAT
APRIL 13, 2025
In an unusual move, an audit of commercial health plans by Tennessee officials found that Express Scripts, one of the largest pharmacy benefit managers in the United States, violated state laws in its dealings with pharmacies, according to newly released documents. A department spokesperson declined to comment.
Drug Topics
JULY 1, 2025
They look at the list and they prioritize who they want to take on and who they don't want to take on based on their insurance plan and their drugs. That's dependent upon their insurance plan and the medications they use. I am hearing that some independents are just creating a wait list. That is a real problem.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
JUNE 5, 2025
Some health insurance formularies cover Mounjaro, while others list it as a nonpreferred drug. Even if your BCBS health plan covers Mounjaro, you may need to get prior authorization from the insurance company to confirm they’ll pay for it. Without insurance, Mounjaro costs an average of $1,486 per 4, 0.5 mL of 5 mg/0.5
The Checkup by Singlecare
JUNE 5, 2025
While health insurance plans do not always provide coverage of Zepbound for weight loss, coverage may be more likely if the drug is prescribed for sleep apnea. Many insurance plans often do not cover weight loss medications in general,” says Luis Vinas , a board-certified plastic surgeon at Palm Beach Gynecomastia Center.
Pharmacy Times
JULY 1, 2025
We all share the same electronic health record and document every patient interaction in the health record, and we have very easy access to reach out to the patient's provider to let them know of any questions or concerns that the patient has regarding their medication.
Drug Topics
JUNE 25, 2025
image credit: syahrir / stock.adobe.com While data shows that obesity has been on the rise among children in recent history, the overall complications spurred on by childhood obesity have been well documented. 1 “Guidelines recommend treating obesity with medications and lifestyle changes.”
Pharmacy Times
JUNE 23, 2025
Kevin Sayer, CEO of Dexcom, discusses the key barriers to continuous glucose monitoring (CGM) adoption for type 2 diabetes (T2D) in an interview with Pharmacy Times® at the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois. We are getting insurance coverage. We've had major wins this year.
Expert insights. Personalized for you.
145 
Let's personalize your content